Business · 13/12/2023Updated: 10/17/2026 · 1 min read

FDA Establishes Genetic Metabolic Diseases Advisory Committee Under Federal Advisory Committee Act

The Food and Drug Administration (FDA) is establishing the Genetic Metabolic Diseases Advisory Committee, a committee that will advise the agency on genetic metabolic diseases, in accordance with the Federal Advisory Committee Act, with an initial term of 2 years from the date the Charter is filed.